Jüppner et Bergwitz [4] deemed FGF23 as a biomarker for the dysregulation of the phosphate balance in patients with CKD; this biomarker is probably involved in the pathophysiology of cardiovascular events in these patients. The gene discussed is FGF23; the disease is chronic kidney disease.